Schedule of Events

View the 2026 Multidisciplinary Radiopharmaceutical Therapy Symposium schedule.
 

February 16, 2026
4:00 p.m. - 6:00 p.m. Registration Open
South Registration Counter
February 17, 2026
7:00 a.m. - 4:15 p.m. Registration Open
South Registration Counter
7:00 a.m. - 8:00 a.m. Continental Breakfast
Springs Ballroom G
8:00 a.m. - 8:15 a.m. Day One Welcome
Springs Ballroom F
8:15 a.m. - 9:15 a.m. Session I: Radiopharmaceutical Program Justification and Initial Start-up
Springs Ballroom F 

Moderator: Ramji R. Rajendran, MD, PhD, Radiation Oncology Consultants Ltd 
  • Building a Business Case for an RPT Program
    • Dustin L. Boothe, MD, Intermountain Health
  • Space Requirements for RPT Administration 
    • J. Travis Mendel, MD, Rio Grande Cancer Specialists  
  • The RAM License and SOP Development  
    • Ashley Cockerham, MSJ, Mercurie Consulting, LLC 
  • Clinic and Staffing Needs for RPT Delivery  
    • Brett E. Lewis, MD, PhD, Hackensack University Medical Center
9:15 a.m. - 10:00 a.m. Keynote
Springs Ballroom F 

Speaker: Johannes Czernin, MD, University of California
10:00 a.m. - 10:30 a.m. Coffee Break and Poster Browsing in the Exhibit Hall
Springs Ballroom G
10:30 a.m. - 11:30 a.m. Session II: Physicist Training and Authorized User Process
Springs Ballroom F 

Moderator: Xinxin Zhang, PhD, Rutgers Cancer Institute of New Jersey/Robert Wood Johnson University Hospital 
  • The Path to Authorized User for Unsealed Byproduct Material
  • Physicist Training in RPT: The Beginnings of Structured Programs  
    • Robert Hobbs PhD, DABR, Johns Hopkins University  
  • QA and QC for Dose Calibrators, SPECT/CT and PET/CT Systems for Radiopharmaceutical Therapy  
    • John Sunderland, PhD, MBA, The University of Iowa 
11:30 a.m. - 12:00 p.m. Session III: Radiopharmaceutical Therapy Administration and the Role of the QMP
Springs Ballroom F 

Moderator: Jacqueline E. Zoberi, PhD, Washington University of St. Louis
  • Panel Session on RPT Administration and the Role of the QMP
    • Jacqueline E. Zoberi, PhD, Washington University of St. Louis and Joseph G. Dise, MMP, AstraZeneca  
12:00 p.m. - 12:30 p.m. Session IV: Access to Therapy and Addressing Unmet Needs 
Springs Ballroom F

Moderator: Jeffrey Y.C. Wong, MD, FASTRO, City of Hope
  • Increasing Access to Radiopharmaceutical Therapy  
    • Phillip Koo, MD, Prostate Cancer Foundation  
  • Addressing Unmet Needs in Radiopharmaceutical Therapy  
    • Ravi Bhasker Patel, MD, PhD, University of Pittsburgh Medical Center 
12:30 p.m. - 1:30 p.m. Lunch and Poster Browsing in the Exhibit Hall
Springs Ballroom G
1:30 p.m. - 3:00 p.m. Plenary Session I
Springs Ballroom G
3:00 p.m. - 4:15 p.m. Session V: Building Beyond Initial Theranostics: Optimizing Operations, Coordination and Outcomes
Springs Ballroom F

Moderator: Arpit Michael Chhabra, MD, Bridge Oncology, New York Proton Center, Mt. Sinai Health System 
  • Revenue Cycle Management and Prior Authorization Challenges in Theranostics Programs  
    • Adam Brown, MBA, NMTCB, Integrated Theranostics Solutions 
  • Multidisciplinary Care Coordination Across Referring Providers    
    • Munir Ghesani, MD, United Theranostics 
  • Workflow Optimization: Software Utilization and Tracking Systems   
    • Erik Mittra, MD, PhD, Oregon Health and Science University  
  • Clinical Trials Development in Theranostics Programs: Practical Considerations   
    • Adam Brown, MBA, NMTCB, Integrated Theranostics Solutions 
4:15 p.m. - 5:30 p.m. Poster Session and Networking in the Exhibit Hall
Springs Ballroom G
February 18, 2026
7:00 a.m. - 3:00 p.m. Registration Open
South Registration Counter
7:00 a.m. - 8:00 a.m. Continental Breakfast
Springs Ballroom G
8:00 a.m. - 8:15 a.m. Day Two Welcome
Springs Ballroom F
8:15 a.m. - 9:15 a.m. Session VI: Experiences in Collaboration: A Tale of 3 Institutions 
Springs Ballroom F 

Moderator: Erin Grady, MD, Stanford University  
  • The Penn Medicine Experience  
    • Neil Kanth Taunik, MD, MS, Unversity of Pennsylvania
    • Philipose G. Mulugeta, MD, University of Pennsylvania 
  • The Intermountain Health Experience   
    • Dustin L. Boothe, MD, Intermountain Health
    • Eric Hu, MD, MBA, MPH, Intermountain Health Clinic  
  • The Stanford Experience  
    • Erin Grady, MD, Stanford University
    • Mallika Marar, MD, MBA, Stanford University
9:15 a.m. - 10:00 a.m. Session VII: Unique Challenges with Clinical Trials for Radiopharmaceutical Therapy
Springs Ballroom F

Moderator: Jeff Michalski, MD, MBA, FASTRO, Washington University of St. Louis 
  • RPT Clinical Trials — an Investigator and Drug Development Perspective
    • Scott T. Tagawa, MD, New York-Presbyterian Hospital/Weill Cornell Medical Center
  • RPT Trial Challenges in the National Clinical Trials Network
    • Jonathan E. McConathy, MD, The University of Alabama at Birmingham
  • Industry Perspective and Regulatory Challenges for RPT Clinical Trials
    • Michael Morris, MD, Memorial Sloan Kettering Cancer Center
10:00 a.m. - 10:30 a.m. Coffee Break and Poster Browsing in the Exhibit Hall
Springs Ballroom G 
10:30 a.m. - 11:30 a.m. Session VIII: Clinical Challenges in Radiopharmaceutical Therapy
Springs Ballroom F

Moderator: Ana P. Kiess, MD, PhD, Johns Hopkins
  • Infusion Troubleshooting and Radiation Safety Challenges with RPT 
    • Hyun Kim, MD, City of Hope  
  • Navigating Hematologic and Renal Dysfunction in RPT for Prostate Cancer 
    • Russell Szmulewitz, MD, University of Chicago    
  • When Should We Stop or Pause Treatment with RPT? 
    • Ana P. Kiess, MD, PhD, Johns Hopkins 
11:30 a.m. - 12:30 p.m. Session IX: Looking to the Future: Novel Targets
Springs Ballroom F

Moderator: Neil Kanth Taunk, MD, MS, University of Pennsylvania 
12:30 p.m. - 1:30 p.m. Lunch and Poster Browsing in the Exhibit Hall
Springs Ballroom G 
1:30 p.m. - 3:00 p.m. Plenary Session II
Springs Ballroom F
3:00 p.m. - 3:45 p.m. Session X: Current Status and Challenges of Dosimetry
Springs Ballroom F

Moderator: Robert Hobbs, PhD, DABR, Johns Hopkins
  • Status of RPT Dosimetry Methods and Results  
    • Yuni Dewaraja, MS, PhD, University of Michigan 
  • QA and Harmonization in RPT   
3:45 p.m. - 4:15 p.m. Coffee Break and Poster Browsing in the Exhibit Hall
Springs Ballroom G
4:15 p.m. - 5:00 p.m. Session XI: Radiobiological and Translational Aspects of RPTs  
Springs Ballroom F

Moderator: Terence M. Williams, MD, PhD, City of Hope 
  • Radiobiological and Translational Aspects of RPT    
    • Zachary Scott Morris, MD, PhD, University of Wisconsin School of Medicine and Public Health 
  • Translational Aspects of RPT    
    • Anna Wu, PhD, City of Hope 

American Society for Radiation Oncology
251 18th Street South, 8th Floor
Arlington, VA 22202
Telephone: 703-502-1550
www.astro.org

TERMS OF USE & PRIVACY POLICY

Connect With Us: